Until 2004, hepatitis A was the most frequently reported type of hepatitis in the United States. In the prevaccine era, the primary methods used for preventing hepatitis A were hygienic measures and passive protection with immune globulin (IG). Hepatitis A vaccines were licensed in 1995 and 1996. These vaccines provide long-term protection against hepatitis A virus (HAV) infection. The similarities between the epidemiology of hepatitis A and poliomyelitis suggest that widespread vaccination of appropriate susceptible populations can substantially lower disease incidence, eliminate virus transmission, and ultimately, eliminate HAV infection. For more information click here.
Recent Posts
Archives
- November 2023
- August 2023
- July 2023
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- November 2021
- October 2021
- September 2021
- January 2021
- December 2020
- August 2020
- May 2020
- April 2020
- December 2019
- November 2019
- October 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- January 2019
Recent Comments